{"id":"optimized-drug-therapy","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL157030","moleculeType":"Small molecule","molecularWeight":"883.99"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"This appears to be an optimized drug therapy in phase 3 development by an Italian cardiovascular research center, but specific mechanistic details, molecular targets, and pharmacological properties are not publicly disclosed or available in standard pharmaceutical databases.","oneSentence":"Unknown mechanism; insufficient public data available for this investigational therapy.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:24:38.927Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Cardiovascular disease prevention (inferred from sponsor focus)"}]},"trialDetails":[{"nctId":"NCT04351256","phase":"PHASE2","title":"Thoracic Radiotherapy Plus Durvalumab in Elderly and/or Frail NSCLC Stage III Patients Unfit for Chemotherapy","status":"COMPLETED","sponsor":"Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest","startDate":"2020-05-20","conditions":"NSCLC, Stage III","enrollment":51},{"nctId":"NCT03569891","phase":"PHASE3","title":"HOPE-B: Trial of AMT-061 in Severe or Moderately Severe Hemophilia B Patients","status":"COMPLETED","sponsor":"CSL Behring","startDate":"2018-06-27","conditions":"Hemophilia B","enrollment":67},{"nctId":"NCT07493655","phase":"NA","title":"Therapeutic Drug Monitoring of Mycophenolate Mofetil in Lupus Nephritis","status":"NOT_YET_RECRUITING","sponsor":"Federal University of Maranhao","startDate":"2026-07-01","conditions":"Systemic Lupus Erythematosus, Lupus Nephritis, Drug Monitoring","enrollment":100},{"nctId":"NCT07471802","phase":"","title":"Monitoring of the Sympathetic/Vagal Balance Through Multiparametric Analysis of Heart Rate Variability (HRV)","status":"NOT_YET_RECRUITING","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2026-03-25","conditions":"Diabete Type 2, Heart Failure, Kidney Disease, Chronic","enrollment":150},{"nctId":"NCT07005102","phase":"PHASE2, PHASE3","title":"A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer","status":"RECRUITING","sponsor":"AbbVie","startDate":"2025-08-03","conditions":"Non-Squamous Non-Small Cell Lung Cancer","enrollment":854},{"nctId":"NCT07486206","phase":"NA","title":"Optimizing the Follow-Up Journey in Interstitial Lung Disease: The OPTIMIZE-ILD-2 Trial","status":"RECRUITING","sponsor":"Hospital de Granollers","startDate":"2026-03-09","conditions":"Interstitial Lung Disease (ILD), Fibrotic Interstitial Lung Disease, Idiopathic Pulmonary Fibrosis (IPF)","enrollment":152},{"nctId":"NCT03635073","phase":"PHASE2","title":"A Study of Soticlestat in Adults and Children With Rare Epilepsies","status":"TERMINATED","sponsor":"Takeda","startDate":"2018-07-19","conditions":"Epilepsy, Dravet Syndrome (DS), Lennox-Gastaut Syndrome (LGS)","enrollment":156},{"nctId":"NCT07482917","phase":"NA","title":"Optimizing the Diagnostic Journey in Interstitial Lung Disease: The OPTIMIZE-ILD-1 Trial","status":"RECRUITING","sponsor":"Hospital de Granollers","startDate":"2026-03-09","conditions":"Interstitial Lung Disease (ILD), Suspected Interstitial Lung Disease, Fibrotic Interstitial Lung Disease","enrollment":92},{"nctId":"NCT06451120","phase":"PHASE2","title":"Platelet Rich Plasma Injections In Young And Old Human Subjects","status":"RECRUITING","sponsor":"University of California, San Francisco","startDate":"2024-06-01","conditions":"Osteoarthritis, Articular Cartilage, Musculoskeletal Disorders","enrollment":60},{"nctId":"NCT04119024","phase":"PHASE1","title":"Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors","status":"RECRUITING","sponsor":"Anusha Kalbasi","startDate":"2025-10-07","conditions":"Metastatic Malignant Solid Neoplasm, Metastatic Melanoma, Pathologic Stage IIIC Cutaneous Melanoma AJCC v8","enrollment":18},{"nctId":"NCT06871488","phase":"PHASE4","title":"Predictors of Improvements in Irritability and Aggression in Children With ADHD Treated With CNS Stimulants","status":"RECRUITING","sponsor":"Milton S. Hershey Medical Center","startDate":"2026-03-05","conditions":"ADHD - Attention Deficit Disorder With Hyperactivity, Irritability, Aggression Childhood","enrollment":136},{"nctId":"NCT04150068","phase":"PHASE2, PHASE3","title":"Study to Evaluate the Safety and Efficacy of Lenacapavir (GS-6207) in Combination With an Optimized Background Regimen (OBR) in Heavily Treatment Experienced Participants Living With HIV-1 Infection With Multidrug Resistance","status":"ACTIVE_NOT_RECRUITING","sponsor":"Gilead Sciences","startDate":"2019-11-21","conditions":"HIV-1-infection","enrollment":72},{"nctId":"NCT07470502","phase":"NA","title":"MICI-BIO: Study on Patient With Chronic Inflammatory Bowel Disease","status":"RECRUITING","sponsor":"Meyer Children's Hospital IRCCS","startDate":"2025-02-13","conditions":"IBD (Inflammatory Bowel Disease)","enrollment":15},{"nctId":"NCT07079631","phase":"PHASE1, PHASE2","title":"A Clinical Study to Test if an Investigational Treatment Called BNT314 When Used in Combination With Another Investigational Treatment BNT327 and Chemotherapy, is Beneficial and Safe for Patients With Advanced Colorectal Cancer","status":"RECRUITING","sponsor":"BioNTech SE","startDate":"2025-07-18","conditions":"Metastatic Colorectal Cancer","enrollment":482},{"nctId":"NCT07345884","phase":"NA","title":"Treatment of Severe Acute Malnutrition in Children 6 to 59 Months Old With Standard Ready To Use Therapeutic Food Compared to a Newly Formulated Lipid Optimized Ready To Use Therapeutic Food","status":"NOT_YET_RECRUITING","sponsor":"University of California, Los Angeles","startDate":"2026-02","conditions":"Severe Acute Malnutrition in Childhood, Malnutrition, Child, Neurocognition, Child","enrollment":125},{"nctId":"NCT04510051","phase":"PHASE1","title":"CAR T Cells After Lymphodepletion for the Treatment of IL13Rα2 Positive Recurrent or Refractory Brain Tumors in Children","status":"RECRUITING","sponsor":"City of Hope Medical Center","startDate":"2020-12-04","conditions":"Malignant Brain Neoplasm, Recurrent Malignant Brain Neoplasm, Refractory Malignant Brain Neoplasm","enrollment":18},{"nctId":"NCT05520567","phase":"PHASE1, PHASE2","title":"A Study of Gilteritinib, Venetoclax and Azacitidine as a Combined Treatment for People Newly Diagnosed With Acute Myeloid Leukemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"Astellas Pharma Global Development, Inc.","startDate":"2023-01-31","conditions":"Acute Myeloid Leukemia (AML), FLT3-mutated Acute Myeloid Leukemia","enrollment":70},{"nctId":"NCT03326336","phase":"PHASE1, PHASE2","title":"Dose-escalation Study to Evaluate the Safety and Tolerability of GS030 in Subjects With Retinitis Pigmentosa","status":"ACTIVE_NOT_RECRUITING","sponsor":"GenSight Biologics","startDate":"2018-09-26","conditions":"Non-syndromic Retinitis Pigmentosa","enrollment":10},{"nctId":"NCT05017311","phase":"PHASE4","title":"Optimized Predictive Treatment In Medications for Unipolar Major Depression (OPTIMUM-D)","status":"RECRUITING","sponsor":"Nova Scotia Health Authority","startDate":"2023-01-20","conditions":"Major Depressive Disorder","enrollment":400},{"nctId":"NCT06449222","phase":"PHASE2","title":"Safety and Preliminary Effectiveness of BNT327, an Investigational Therapy for Breast Cancer, When Given in Combination With Chemotherapy","status":"ACTIVE_NOT_RECRUITING","sponsor":"BioNTech SE","startDate":"2024-08-26","conditions":"Locally Advanced Breast Cancer, Triple Negative Breast Cancer, Metastatic Triple Negative Breast Cancers","enrollment":83},{"nctId":"NCT06236438","phase":"PHASE2, PHASE3","title":"Study to Evaluate Adverse Events, Optimal Dose, and Change in Disease Activity, With Livmoniplimab in Combination With Budigalimab Plus Chemotherapy Versus IV Infused Pembrolizumab Plus Chemotherapy in Adult Participants With Untreated Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC)","status":"RECRUITING","sponsor":"AbbVie","startDate":"2024-04-10","conditions":"Non-Small Cell Lung Cancer","enrollment":840},{"nctId":"NCT07424690","phase":"NA","title":"Catheter Ablation vs Conservative Care in Elderly Patients With Atrial Fibrillation","status":"NOT_YET_RECRUITING","sponsor":"Karolinska University Hospital","startDate":"2026-05-20","conditions":"Atrial Fibrillation (AF), Atrial Fibrillation Ablation, Elderly","enrollment":282},{"nctId":"NCT05914467","phase":"PHASE4","title":"TDM-optimized Teicoplanin Dosing Versus Standard of Care","status":"ACTIVE_NOT_RECRUITING","sponsor":"Radboud University Medical Center","startDate":"2023-08-01","conditions":"Bacterial Infections","enrollment":74},{"nctId":"NCT05197270","phase":"PHASE1, PHASE2","title":"4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration","status":"RECRUITING","sponsor":"4D Molecular Therapeutics","startDate":"2021-12-09","conditions":"Neovascular (Wet) Age-Related Macular Degeneration","enrollment":215},{"nctId":"NCT07407660","phase":"PHASE3","title":"Shortened Venetoclax Duration Based on Day 14 BM Blasts Versus Standard Therapy in Elderly or Frail Patients With AML Patients Treated With Azacitidine Plus Venetoclax","status":"NOT_YET_RECRUITING","sponsor":"Peking University People's Hospital","startDate":"2026-02-01","conditions":"Acute Myeloid Leukemia","enrollment":250},{"nctId":"NCT07406958","phase":"","title":"Advanced Classification of Colon Tumors From CT Scans Using Deep Learning for Optimized Treatment Decision-making.","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2026-02","conditions":"Colonic Neoplasm","enrollment":1000},{"nctId":"NCT02203396","phase":"PHASE2","title":"A Single-Arm Phase 2 Study With Optimized Standard Protocol for Severe Aplastic Anemia","status":"COMPLETED","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2014-08","conditions":"Aplastic Anemia","enrollment":40},{"nctId":"NCT03389230","phase":"PHASE1","title":"Memory-Enriched T Cells in Treating Patients With Recurrent or Refractory Grade III-IV Glioma","status":"ACTIVE_NOT_RECRUITING","sponsor":"City of Hope Medical Center","startDate":"2018-08-14","conditions":"Glioblastoma, Malignant Glioma, Recurrent Glioma","enrollment":29},{"nctId":"NCT07344363","phase":"","title":"Prostate Cancer REsearch Using Cross-validation of Innovative Sampling, Integrating LC-MS/MS for Optimized Therapeutic Drug moNitoring","status":"RECRUITING","sponsor":"Centro di Riferimento Oncologico - Aviano","startDate":"2025-11-19","conditions":"Prostate Cancer","enrollment":100},{"nctId":"NCT06301477","phase":"NA","title":"PRecisiOn Microbiome Directed ExtensiOn of Anti-TNFα Crohn's Disease ThErapy in Children: The PROMOTE Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Hospital of Eastern Ontario","startDate":"2024-12-01","conditions":"Inflammatory Bowel Diseases, Crohn Disease","enrollment":45},{"nctId":"NCT07363161","phase":"NA","title":"Drug-coated Balloon (DCB) vs. Drug-eluting Stent (DES) in High-risk Patients With Coronary Artery Disease (CAD)","status":"NOT_YET_RECRUITING","sponsor":"B. Braun Melsungen AG","startDate":"2026-03-01","conditions":"Coronary Artery Disease (CAD)","enrollment":2184},{"nctId":"NCT06013423","phase":"PHASE2","title":"Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases","status":"RECRUITING","sponsor":"Fred Hutchinson Cancer Center","startDate":"2024-07-23","conditions":"Acute Leukemia of Ambiguous Lineage, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia","enrollment":54},{"nctId":"NCT07361250","phase":"NA","title":"Subthalamic Nucleus (STN) Targeted Transcranial Temporal Interference Stimulation (TIS) Treats Parkinson's Disease","status":"NOT_YET_RECRUITING","sponsor":"Tang Zhouping","startDate":"2026-01-20","conditions":"Parkinson Disease","enrollment":20},{"nctId":"NCT04935606","phase":"NA","title":"mHealth to Enhance & Sustain Drug Use Reduction of the QUIT BI in Primary Care","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of California, Los Angeles","startDate":"2021-06-01","conditions":"Drug Use","enrollment":458},{"nctId":"NCT04629248","phase":"PHASE3","title":"A Study Evaluating the Efficacy and Safety of Obinutuzumab in Participants With Primary Membranous Nephropathy","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hoffmann-La Roche","startDate":"2021-06-25","conditions":"Primary Membranous Nephropathy","enrollment":142},{"nctId":"NCT06385652","phase":"EARLY_PHASE1","title":"PET Imaging Study of 68Ga-NB381 in Multiple Myeloma","status":"RECRUITING","sponsor":"Peking University First Hospital","startDate":"2024-04-01","conditions":"Multiple Myeloma","enrollment":30},{"nctId":"NCT07319793","phase":"NA","title":"Pre-DLI or Pro-DLI in Relapsed/Refractory Myeloid Neoplasms After HSCT","status":"NOT_YET_RECRUITING","sponsor":"Peking University People's Hospital","startDate":"2026-01-01","conditions":"Acute Myeloid Leukemia, Myelodysplastic Syndromes (MDS)","enrollment":200},{"nctId":"NCT06994975","phase":"PHASE3","title":"CHinese ischEmic Stroke Beyond 4.5 Hours With TeNecteplase Under Optimized Non-Contrast CT Selection","status":"RECRUITING","sponsor":"Huashan Hospital","startDate":"2025-11-03","conditions":"Acute Ischemic Stroke","enrollment":890},{"nctId":"NCT07073365","phase":"PHASE2","title":"Bolstering Outcomes After Induction With Osimertinib Plus Chemotherapy Through Optimized Site-Directed Primary Tumor Therapy (BOOST Trial)","status":"RECRUITING","sponsor":"Pusan National University Hospital","startDate":"2025-07-01","conditions":"Non-Small Cell Lung Cancer, Epidermal Growth Factor Receptor","enrollment":70},{"nctId":"NCT07307053","phase":"PHASE1, PHASE2","title":"Rare Tumor Focused Platform Study of Innovative Therapies and Technologies (PLATFORM2)","status":"NOT_YET_RECRUITING","sponsor":"Cancer Institute and Hospital, Chinese Academy of Medical Sciences","startDate":"2026-01-01","conditions":"Rare Malignant Neoplasm, Advanced Solid Tumors, Metastatic Solid Tumors","enrollment":600},{"nctId":"NCT07298876","phase":"NA","title":"Low-intensity Hippocampal Transcranial Ultrasound Stimulation for Managing Cognitive and Sleep Dysfunction in Preclinical Alzheimer's Disease","status":"ENROLLING_BY_INVITATION","sponsor":"Chinese University of Hong Kong","startDate":"2026-04-01","conditions":"Sleep Disturbances, Aging, Cognitive Impairment, Mild","enrollment":20},{"nctId":"NCT07283575","phase":"","title":"Using ctDNA Methylation to Monitor Metastatic Colorectal Cancer Treatment (PROMET)","status":"RECRUITING","sponsor":"Fudan University","startDate":"2025-10-10","conditions":"Metastatic Colorectal Cancer ctDNA Surveillance","enrollment":497},{"nctId":"NCT07279909","phase":"PHASE3","title":"Phase-III Clinical Studies on Poly Herbal Anti-Diabetic Formulation","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hamdard University","startDate":"2024-03-09","conditions":"Diabetes Type 2, Diabetes Mellitus, Experimental, HbA1c","enrollment":500},{"nctId":"NCT02146924","phase":"PHASE1","title":"Cellular Immunotherapy in Treating Patients With High-Risk Acute Lymphoblastic Leukemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"City of Hope Medical Center","startDate":"2014-10-16","conditions":"B Acute Lymphoblastic Leukemia, Recurrent Acute Lymphoblastic Leukemia, Refractory Acute Lymphoblastic Leukemia","enrollment":71},{"nctId":"NCT07265037","phase":"NA","title":"Integrated TCM - Western Medicine Strategy for Long - Distance Diabetes Management","status":"RECRUITING","sponsor":"Shanxi Bethune Hospital","startDate":"2025-11-01","conditions":"Diabetes Mellitus, Type 2, Integrated Traditional Chinese Medicine and Western Medicine, Telemedicine","enrollment":10000},{"nctId":"NCT06807606","phase":"PHASE2","title":"Optimized Cord Blood Transplantation for the Treatment of Patients With High-risk Hematologic Malignancies Who Have Relapsed After First Allogeneic Stem Cell Transplantation","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2025-03-03","conditions":"Hematologic Malignancies","enrollment":35},{"nctId":"NCT06806098","phase":"NA","title":"Cessation Clinical Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"Truth Initiative","startDate":"2024-12-05","conditions":"Tobacco Use Cessation","enrollment":2220},{"nctId":"NCT07204834","phase":"NA","title":"A Physical Activity Program for People With Heart Failure","status":"ENROLLING_BY_INVITATION","sponsor":"Universidad de Granada","startDate":"2025-10-08","conditions":"Heart Failure","enrollment":200},{"nctId":"NCT05111353","phase":"PHASE1","title":"Neoantigen Vaccines in Pancreatic Cancer in the Window Prior to Surgery","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2022-12-15","conditions":"Pancreas Cancer, Pancreatic Cancer, Cancer of the Pancreas","enrollment":33},{"nctId":"NCT06574009","phase":"PHASE4","title":"Better Options for Chronic Cancer Pain","status":"RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2025-10-07","conditions":"Chronic Pain, Cancer Survivor, Opioid Dependence","enrollment":294},{"nctId":"NCT03452774","phase":"","title":"SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry","status":"RECRUITING","sponsor":"Massive Bio, Inc.","startDate":"2018-01-01","conditions":"Cancer, Metastatic, Cancer, Cancer of Pancreas","enrollment":50000},{"nctId":"NCT02153580","phase":"PHASE1","title":"Cellular Immunotherapy Following Chemotherapy in Treating Patients With Recurrent Non-Hodgkin Lymphomas, Chronic Lymphocytic Leukemia, or B-Cell Prolymphocytic Leukemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"City of Hope Medical Center","startDate":"2014-09-24","conditions":"B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma, B-Cell Prolymphocytic Leukemia, High Grade B-Cell Lymphoma, Not Otherwise Specified","enrollment":37},{"nctId":"NCT03748966","phase":"EARLY_PHASE1","title":"Calcitriol Monotherapy for X-Linked Hypophosphatemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2019-03-28","conditions":"X-linked Hypophosphatemia, Hypophosphatemic Rickets, Hypophosphatemic Rickets, X-Linked Dominant","enrollment":20},{"nctId":"NCT07200947","phase":"PHASE2","title":"A Phase II Study of QL1706 and Platinum-Based Chemotherapy in Patients With SMARCA4-Deficient, Locally Advanced or Metastatic Non-Small Cell Lung Cancer.","status":"NOT_YET_RECRUITING","sponsor":"Zhijie Wang","startDate":"2025-12-01","conditions":"SMARCA4-Deficient Tumor, Locally Advanced or Metastatic Non-Small Cell Lung Cancer","enrollment":28},{"nctId":"NCT04829318","phase":"PHASE4","title":"A Long-Term Extension Study for Participants With Treatment-resistant Major Depressive Disorder Who Are Continuing Esketamine Nasal Spray Treatment","status":"COMPLETED","sponsor":"Janssen-Cilag Ltd.","startDate":"2021-04-26","conditions":"Depressive Disorder, Major","enrollment":183},{"nctId":"NCT07177300","phase":"PHASE4","title":"Effectiveness of Nontraditional Hydroxyurea Algorithms: Novel and Clinical Evaluations (ENHANCE)","status":"RECRUITING","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2024-12-19","conditions":"Sickle Cell Anemia (HbSS), Sickle-β0-thalassemia (HbSβ0)","enrollment":50},{"nctId":"NCT06646302","phase":"NA","title":"Residual Inhibition of 40 Hz Burst Sound in Tinnitus Patients","status":"COMPLETED","sponsor":"Eye & ENT Hospital of Fudan University","startDate":"2024-10-28","conditions":"Tinnitus","enrollment":265},{"nctId":"NCT06970080","phase":"PHASE4","title":"Therapeutic Relevance of Abnormal Airway Morphology in Asthma","status":"RECRUITING","sponsor":"McMaster University","startDate":"2025-06-02","conditions":"Asthma","enrollment":242},{"nctId":"NCT05884333","phase":"PHASE2","title":"Cord Blood Transplant in Adults With Blood Cancers","status":"RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2023-05-22","conditions":"Acute Myelogenous Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Chronic Myelogenous Leukemia (CML)","enrollment":54},{"nctId":"NCT04105166","phase":"PHASE1","title":"Gene Therapy for Pyruvate Kinase Deficiency (PKD)","status":"COMPLETED","sponsor":"Rocket Pharmaceuticals Inc.","startDate":"2020-07-06","conditions":"Pyruvate Kinase Deficiency","enrollment":4},{"nctId":"NCT05862103","phase":"","title":"Long-Term Follow-Up in Patients With Acute Myocardial Infarction Cohort","status":"RECRUITING","sponsor":"Yu Bo","startDate":"2022-12-21","conditions":"Acute Myocardial Infarction, Adverse Event","enrollment":15000},{"nctId":"NCT07146594","phase":"PHASE4","title":"Clinical Evaluation of a 14day Modified Bismuth Quadruple Therapy for the Eradication of Helicobacter Pylori in a High Clarithromycin and Metronidazole Resistance Area Regarding Patients With Peptic Ulcer and Non Ulcer Dyspepsia","status":"NOT_YET_RECRUITING","sponsor":"Athens Medical Center","startDate":"2025-08-20","conditions":"Helicobacter Pylori Gastritis, Helicobacter Eradication","enrollment":150},{"nctId":"NCT06980012","phase":"NA","title":"Evaluation of the Impact of the Clinical Pharmacist in Oral Therapies in Oncology.","status":"RECRUITING","sponsor":"Polyclinique Lyon Nord","startDate":"2024-12-31","conditions":"Neoplasm","enrollment":90},{"nctId":"NCT07134413","phase":"PHASE2","title":"QL1706/Bevacizumab ± Chemotherapy in Post-ICI Non-Squamous NSCLC","status":"NOT_YET_RECRUITING","sponsor":"Guangdong Association of Clinical Trials","startDate":"2025-08","conditions":"NSCLC","enrollment":77},{"nctId":"NCT07131345","phase":"PHASE1, PHASE2","title":"Study of Iparomlimab and Tuvonralimab Plus Chemotherapy in Malignant Mesothelioma","status":"NOT_YET_RECRUITING","sponsor":"National Cancer Center, China","startDate":"2025-09-01","conditions":"Malignant Mesothelioma, Mesothelioma","enrollment":55},{"nctId":"NCT05899114","phase":"NA","title":"Less Is More: Optimized Pharmacotherapy With Improved coNtinuity of CarE in hospitaLized oLder peOple","status":"ACTIVE_NOT_RECRUITING","sponsor":"Radboud University Medical Center","startDate":"2023-06-05","conditions":"Polypharmacy, Medication Review","enrollment":2576},{"nctId":"NCT06057623","phase":"","title":"Neuromuscular Fatigue and Exercise Capacity in Patients With Type 2 Diabetes Mellitus and HFpEF","status":"COMPLETED","sponsor":"Istituti Clinici Scientifici Maugeri SpA","startDate":"2023-06-15","conditions":"Diabetes Mellitus, Type 2, Heart Failure Preserved Ejection Fraction","enrollment":21},{"nctId":"NCT07090200","phase":"NA","title":"Rehabilitation Intervention for COPD Combined With Cardiovascular and Cerebrovascular Diseases","status":"RECRUITING","sponsor":"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","startDate":"2025-09-01","conditions":"Respiratory Diseases, Cardiovascular Diseases, Cerebrovascular Diseases","enrollment":50000},{"nctId":"NCT04188873","phase":"PHASE4","title":"Cessation Screening Project","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2020-12-10","conditions":"Nicotine Dependence","enrollment":529},{"nctId":"NCT05174312","phase":"NA","title":"Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve Decongestion Management System (DMS)","status":"COMPLETED","sponsor":"Reprieve Cardiovascular, Inc","startDate":"2022-07-11","conditions":"Acute Decompensated Heart Failure","enrollment":100},{"nctId":"NCT06953882","phase":"PHASE2","title":"Impact of Omitting Chemo Based on Patient's Selection for ER-Positive, HER2-Negative Breast Cancer With Ribociclib and Endocrine Therapy","status":"RECRUITING","sponsor":"Yale University","startDate":"2025-07-09","conditions":"HER2 Negative Breast Cancer","enrollment":140},{"nctId":"NCT05582694","phase":"PHASE2","title":"A Trial of Anti-CD4 Antibody UB-421 in Combination With Optimized Background Antiretroviral Therapy in Patients With Multi-Drug Resistant HIV-1 Infection","status":"WITHDRAWN","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2025-07-10","conditions":"Multi-Drug Resistant Hiv-1 Infection, HIV-1 Infection","enrollment":""},{"nctId":"NCT07059741","phase":"NA","title":"Integrated Radiotherapy-optimized ASCT Sequential CAR-T Therapy for Patients With Relapsed and Refractory B-NHL","status":"RECRUITING","sponsor":"The First Affiliated Hospital of Soochow University","startDate":"2024-12-10","conditions":"Aggressive B-Cell Non-Hodgkin's Lymphoma (NHL)","enrollment":20},{"nctId":"NCT05824169","phase":"PHASE1, PHASE2","title":"Evaluation of Safety and Efficacy of Gene Therapy Drug in the Treatment of Spinal Muscular Atrophy (SMA) Type 1 Patients","status":"RECRUITING","sponsor":"GeneCradle Inc","startDate":"2023-02-25","conditions":"Spinal Muscular Atrophy","enrollment":18},{"nctId":"NCT05901987","phase":"PHASE1, PHASE2","title":"Evaluation of Safety and Efficacy of Gene Therapy Drug in the Treatment of Spinal Muscular Atrophy (SMA) Type 2 Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"GeneCradle Inc","startDate":"2023-08-01","conditions":"SMA II","enrollment":33},{"nctId":"NCT06421831","phase":"PHASE1, PHASE2","title":"Evaluation of Safety and Efficacy of Gene Therapy Drug in the Treatment of Spinal Muscular Atrophy (SMA) Type 3 Patients","status":"RECRUITING","sponsor":"GeneCradle Inc","startDate":"2024-05-10","conditions":"Spinal Muscular Atrophy Type 3","enrollment":21},{"nctId":"NCT05860569","phase":"PHASE1","title":"Safety Evaluation of Gene Therapy Drug in the Treatment of Primary Hypertriglyceridemic Patients With Recurrent Pancreatitis","status":"RECRUITING","sponsor":"GeneCradle Inc","startDate":"2024-09-20","conditions":"Hypertriglyceridemia, Familial","enrollment":7},{"nctId":"NCT07040995","phase":"NA","title":"Facilitated Access to Optimized Treatment and Clinical Follow-Up for Elderly Patients by the Internal Medicine Heart Failure Outpatient Clinic - a Randomized Multicenter Prospective Study","status":"WITHDRAWN","sponsor":"Region Skane","startDate":"2025-01-01","conditions":"Heart Failure","enrollment":""},{"nctId":"NCT06010732","phase":"PHASE3","title":"In Situ Comparison of the Remineralization Potential of Optimized Fluoride Dentifrice With Control Fluoride Dentifrice","status":"COMPLETED","sponsor":"Indiana University","startDate":"2023-10-02","conditions":"Caries","enrollment":52},{"nctId":"NCT05248685","phase":"PHASE1","title":"Optimized Dual CD33/CLL1 CAR T Cells in Subjects With Refractory or Relapsed Acute Myeloid Leukemia","status":"WITHDRAWN","sponsor":"Beijing Boren Hospital","startDate":"2022-02-16","conditions":"Acute Myeloid Leukemia","enrollment":""},{"nctId":"NCT06998173","phase":"PHASE1","title":"Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of DAT-1604 in Advanced Solid Tumor","status":"NOT_YET_RECRUITING","sponsor":"Danatlas Pharmaceuticals Co., Ltd","startDate":"2025-07-31","conditions":"Advanced Solid Tumors","enrollment":228},{"nctId":"NCT06989567","phase":"PHASE3","title":"A Study of Intravenous L-Citrulline in Patients Aged 6-21 Years Old With Sickle Cell Disease Presenting to Emergency Departments in Acute Vaso-Occlusive Crisis","status":"NOT_YET_RECRUITING","sponsor":"Asklepion Pharmaceuticals, LLC","startDate":"2025-07-25","conditions":"Sickle Cell Disease","enrollment":120},{"nctId":"NCT06993636","phase":"","title":"Pharmacometrics Analysis of Rivaroxaban in Chinese Children Aged Over 2 Years","status":"RECRUITING","sponsor":"Children's Hospital of Fudan University","startDate":"2023-01-01","conditions":"Kawasaki Disease, Coronary Artery Aneurysm, Rivaroxaban","enrollment":60},{"nctId":"NCT06977074","phase":"PHASE2","title":"PROPHET Study: ctDNA-Guided Personalized Induction Immunochemotherapy for NSCLC","status":"RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2025-05-10","conditions":"Non-small Cell Lung Cancer (NSCLC)","enrollment":83},{"nctId":"NCT04483440","phase":"PHASE1","title":"Dose Escalation Study of Intravitreal 4D-110 in Patients With Choroideremia","status":"ACTIVE_NOT_RECRUITING","sponsor":"4D Molecular Therapeutics","startDate":"2020-06-02","conditions":"Choroideremia","enrollment":13},{"nctId":"NCT05696093","phase":"PHASE3","title":"Efficacy of Cotrimoxazole as a De-escalation Treatment of Ventilator-Associated Pneumonia in Intensive Care Unit","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2023-10-19","conditions":"Ventilator Associated Pneumonia","enrollment":628},{"nctId":"NCT06699342","phase":"NA","title":"Pacing of Left Bundle Branch Area and Atroventricular Node ablatIon in Patients With Symptomatic Atrial Fibrillation","status":"RECRUITING","sponsor":"Seoul National University Hospital","startDate":"2025-01-27","conditions":"Atrial Fibrillation (AF)","enrollment":50},{"nctId":"NCT05002309","phase":"PHASE2","title":"Treatment Interrupts Depression Early","status":"RECRUITING","sponsor":"Nova Scotia Health Authority","startDate":"2021-12-02","conditions":"Depression","enrollment":100},{"nctId":"NCT05327803","phase":"PHASE2, PHASE3","title":"Study of Epetraborole in Patients With Treatment-refractory MAC Lung Disease","status":"TERMINATED","sponsor":"AN2 Therapeutics, Inc","startDate":"2022-05-20","conditions":"MAC Lung Disease, Treatment Refractory MAC Lung Disease","enrollment":177},{"nctId":"NCT05009758","phase":"NA","title":"Moving Towards Precision Medicine in United Airways Disease: Unraveling Inflammatory Patterns in Asthmatic Patients With or Without Nasal Polyps","status":"RECRUITING","sponsor":"Medical University of Vienna","startDate":"2021-09-01","conditions":"Asthma, Chronic Rhinosinusitis With Nasal Polyps, Chronic Rhinosinusitis (Diagnosis)","enrollment":30},{"nctId":"NCT03638466","phase":"PHASE2","title":"Exploratory fMRI Study on the Treatment for Impulsive Aggression in Children With ADHD","status":"TERMINATED","sponsor":"Supernus Pharmaceuticals, Inc.","startDate":"2019-05-30","conditions":"Attention Deficit Hyperactivity Disorder (ADHD), Impulsive Aggression","enrollment":7},{"nctId":"NCT04338321","phase":"PHASE3","title":"A Long-term Comparison of Esketamine Nasal Spray Versus Quetiapine Extended Release, Both in Combination With a Selective Serotonin Reuptake Inhibitor/Serotonin-Norepinephrine Reuptake Inhibitor, in Participants With Treatment Resistant Major Depressive Disorder","status":"COMPLETED","sponsor":"Janssen-Cilag International NV","startDate":"2020-08-21","conditions":"Depressive Disorder, Major","enrollment":676},{"nctId":"NCT00664313","phase":"PHASE1, PHASE2","title":"TBTC Study 30: Safety and Tolerability of Low Dose Linezolid in MDR TB","status":"COMPLETED","sponsor":"Centers for Disease Control and Prevention","startDate":"2009-04","conditions":"Multi-drug Resistant Tuberculosis, Extensively Drug Resistant Tuberculosis","enrollment":36},{"nctId":"NCT03710421","phase":"PHASE1","title":"CS1-CAR T Therapy Following Chemotherapy in Treating Patients With Relapsed or Refractory CS1 Positive Multiple Myeloma","status":"RECRUITING","sponsor":"City of Hope Medical Center","startDate":"2019-04-23","conditions":"Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma","enrollment":30},{"nctId":"NCT06847438","phase":"NA","title":"Tailored Electronic Intervention to Improve Therapy in a Diverse Cohort of Patients With Heart Failure","status":"RECRUITING","sponsor":"Emory University","startDate":"2025-03-24","conditions":"Heart Failure","enrollment":4000},{"nctId":"NCT05379712","phase":"PHASE2","title":"Nutritional Supplementation in Head and Neck Cancers","status":"RECRUITING","sponsor":"AHS Cancer Control Alberta","startDate":"2024-10-25","conditions":"Malnourishment, Nutritional Deficiency, Undernutrition","enrollment":81},{"nctId":"NCT04517149","phase":"PHASE1, PHASE2","title":"4D-125 in Patients With X-Linked Retinitis Pigmentosa (XLRP)","status":"ACTIVE_NOT_RECRUITING","sponsor":"4D Molecular Therapeutics","startDate":"2020-06-09","conditions":"X-Linked Retinitis Pigmentosa","enrollment":21},{"nctId":"NCT06877416","phase":"","title":"Analysis of Exploring Optimized Sequential Treatment Strategies of Antibody-Drug Conjugates (ADCs) in HER2-Low-Expressing Breast Cancer","status":"RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2020-01-01","conditions":"Antibody-drug Conjugates, HER2-low Breast Cancer, Breast Neoplasms","enrollment":700},{"nctId":"NCT06651255","phase":"NA","title":"Algorithm-based Management to Reduce the Recurrence of GI Bleeding and Severe Epistaxis in Von Willebrand Disease","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Lille","startDate":"2025-04","conditions":"Von Willebrand Disease (VWD)","enrollment":66},{"nctId":"NCT04831086","phase":"PHASE3","title":"To Optimize Antenatal Management of Women With Pre Term Labor Using Amniocentesis","status":"COMPLETED","sponsor":"Fundacion Clinic per a la Recerca Biomédica","startDate":"2021-05-05","conditions":"Preterm Birth, Preterm Labor, Intra-amniotic Infection","enrollment":247}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":27,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Pharmacological therapy"],"phase":"phase_3","status":"active","brandName":"Optimized drug therapy","genericName":"Optimized drug therapy","companyName":"Centro Prevenzione Malattie Cardiovascolari N. e V. Corbella","companyId":"centro-prevenzione-malattie-cardiovascolari-n-e-v-corbella","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Unknown mechanism; insufficient public data available for this investigational therapy. Used for Cardiovascular disease prevention (inferred from sponsor focus).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}